HCCS expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.818400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.681800E-01
Normal-vs-Stage2
3.426400E-01
Normal-vs-Stage3
4.795200E-01
Normal-vs-Stage4
4.370800E-01
Stage1-vs-Stage2
9.034600E-01
Stage1-vs-Stage3
1.396630E-01
Stage1-vs-Stage4
6.857200E-01
Stage2-vs-Stage3
6.857900E-02
Stage2-vs-Stage4
5.917400E-01
Stage3-vs-Stage4
2.342000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.211800E-01
Normal-vs-AfricanAmerican
1.723210E-01
Normal-vs-Asian
3.177800E-01
Caucasian-vs-AfricanAmerican
4.463800E-01
Caucasian-vs-Asian
8.443800E-01
AfricanAmerican-vs-Asian
5.593000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.382800E-01
Normal-vs-Female
3.322800E-01
Male-vs-Female
5.355000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.420000E-01
Normal-vs-Age(41-60Yrs)
1.881230E-01
Normal-vs-Age(61-80Yrs)
5.050600E-01
Normal-vs-Age(81-100Yrs)
6.354600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.072600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.835800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.690000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.217810E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.024100E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.320800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.580800E-01
Normal-vs-Daily Drinker
3.360400E-01
Normal-vs-Weekly Drinker
5.304000E-01
Normal-vs-Occasional Drinker
2.906600E-01
Normal-vs-Social Drinker
2.994000E-01
Non Drinker-vs-Daily Drinker
2.335000E-01
Non Drinker-vs-Weekly Drinker
7.071400E-01
Non Drinker-vs-Occasional Drinker
6.414000E-02
Non Drinker-vs-Social Drinker
3.500800E-01
Daily Drinker-vs-Weekly Drinker
5.286800E-01
Daily Drinker-vs-Occasional Drinker
4.084200E-01
Daily Drinker-vs-Social Drinker
8.512000E-01
Weekly Drinker-vs-Occasional Drinker
2.331600E-01
Weekly Drinker-vs-Social Drinker
6.410200E-01
Occasional Drinker-vs-Social Drinker
3.439000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.539800E-01
Normal-vs-Grade 2
8.777000E-01
Normal-vs-Grade 3
8.952400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.335200E-01
Grade 1-vs-Grade 3
4.290800E-01
Grade 1-vs-Grade 4
9.539800E-01
Grade 2-vs-Grade 3
7.078000E-01
Grade 2-vs-Grade 4
8.777000E-01
Grade 3-vs-Grade 4
8.952400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.402200E-01
Normal-vs-NonDiabetic
3.722400E-01
Diabetic-vs-NonDiabetic
2.770600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.287610E-01
Normal-vs-NoPancreatitis
4.310800E-01
Pancreatitis-vs-NoPancreatitis
4.087800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.114800E-01
Normal-vs-N1
3.524200E-01
N0-vs-N1
8.383800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.119500E-03
Normal-vs-TP53-NonMutant
7.740200E-02
TP53-Mutant-vs-TP53-NonMutant
3.337200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
